Difference between revisions of "Part:BBa K5322003"
Line 6: | Line 6: | ||
<!-- Add more about the biology of this part here | <!-- Add more about the biology of this part here | ||
− | + | ==Usage and Biology== | |
+ | <p> | ||
+ | Plasm~~~~~~ | ||
+ | </P> | ||
− | < | + | ==Construction of the plasmid== |
− | < | + | <html> |
− | <partinfo> | + | <p> |
+ | In o3119-`````````` | ||
+ | </p> | ||
+ | |||
+ | <style> | ||
+ | .center-img { | ||
+ | text-align:center; | ||
+ | } | ||
+ | </style> | ||
+ | <div class="center-img"> | ||
+ | <img src="https://static.igem.wiki/teams/5322/wet-lab/20-pet29a-j23119-rbs-mfp3-t7.png" alt="pET29a-J23119-RBS-Mfp3-T7" width="300"> | ||
+ | <p align="center"><b>Figure 2-1</b> Plasmid pET29(a)-p<i>J23119-SoxR</i>-T-p<i>SoxS</i>-RBS-<i>Mfp3</i>-T7</p> | ||
+ | </div> | ||
+ | |||
+ | <div class="center-img"> | ||
+ | <img src="https://static.igem.wiki/teams/5101/partpage/phix174e-gel.png" alt="gel" width="500"> | ||
+ | <p align="center"><b>Figure 2-2</b> Colony PCR gel electrophoresis of plasmid pET29(a)-p<i>J23119-SoxR</i>-T-p<i>SoxS</i>-RBS-PhiX174E-T7(1320bp)</p> | ||
+ | </div> | ||
+ | |||
+ | <div class="center-img"> | ||
+ | <img src="https://static.igem.wiki/teams/5101/partpage/phix174e.png" alt="cexu" width="600"> | ||
+ | <p align="center"><b>Figure 2-3</b> plasmid pET29(a)-p<i>J23119-SoxR</i>-T-p<i>SoxS</i>-RBS-PhiX174E-T7 sequencing result</p> | ||
+ | </div> | ||
+ | |||
+ | </html> | ||
+ | |||
+ | ==Protein Expression Validation== | ||
+ | <html> | ||
+ | We verified the performance of the lysis module through dry experiments and plan to complete wet experimental validation of its lytic function in the future. Through literature review and numerical modeling validation, we found that after inducing the expression of antimicrobial peptides and lysis proteins with NO for twenty minutes, the engineered strain will be lysed by the lysis protein and release the antimicrobial peptides. Mathematical modeling confirmed that at this time, the concentration of antimicrobial peptides is sufficient to reach an effective inhibitory concentration. | ||
+ | </html> | ||
+ | |||
+ | ==Sequence and Features== | ||
+ | <partinfo>BBa_K5101004 SequenceAndFeatures</partinfo> | ||
<!-- Uncomment this to enable Functional Parameter display | <!-- Uncomment this to enable Functional Parameter display | ||
− | + | ==Functional Parameters== | |
− | <partinfo> | + | <partinfo>BBa_K5101004 parameters</partinfo> |
<!-- --> | <!-- --> |
Revision as of 11:21, 29 September 2024
Constitutive Mfp53 Expression System
123